Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LGVN

Longeveron (LGVN)

Longeveron Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LGVN
DateTimeSourceHeadlineSymbolCompany
07/19/20244:05PMGlobeNewswire Inc.Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:LGVNLongeveron Inc
07/18/20248:45AMGlobeNewswire Inc.Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:LGVNLongeveron Inc
07/17/20248:00AMGlobeNewswire Inc.Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s DiseaseNASDAQ:LGVNLongeveron Inc
07/10/20247:30AMGlobeNewswire Inc.Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s DiseaseNASDAQ:LGVNLongeveron Inc
07/09/20249:00AMGlobeNewswire Inc.Neha Motwani Elected to Longeveron® Board of DirectorsNASDAQ:LGVNLongeveron Inc
07/08/20249:00AMGlobeNewswire Inc.Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of DirectorsNASDAQ:LGVNLongeveron Inc
06/21/20248:35AMGlobeNewswire Inc.Life Science Virtual Investor Forum Presentations Now Available for Online ViewingNASDAQ:LGVNLongeveron Inc
06/18/20244:48PMGlobeNewswire Inc.Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise TransactionNASDAQ:LGVNLongeveron Inc
06/17/20249:00AMGlobeNewswire Inc.Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024NASDAQ:LGVNLongeveron Inc
06/17/20248:38AMGlobeNewswire Inc.Longeveron Announces Exercise of Warrants for $4.4 Million Gross ProceedsNASDAQ:LGVNLongeveron Inc
06/11/20249:00AMGlobeNewswire Inc.Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac DiseaseNASDAQ:LGVNLongeveron Inc
06/03/20249:00AMGlobeNewswire Inc.Longeveron® Announces Contract Development and Manufacturing Business and First ContractNASDAQ:LGVNLongeveron Inc
05/28/20248:05AMGlobeNewswire Inc.Longeveron® to Attend BIO International Convention 2024NASDAQ:LGVNLongeveron Inc
05/14/20244:05PMGlobeNewswire Inc.Longeveron Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LGVNLongeveron Inc
05/10/20244:05PMGlobeNewswire Inc.Longeveron Announces Board of Directors Planned TransitionsNASDAQ:LGVNLongeveron Inc
05/02/20248:03AMGlobeNewswire Inc.Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:LGVNLongeveron Inc
04/25/20244:05PMGlobeNewswire Inc.Longeveron to Present at the Planet MicroCap ShowcaseNASDAQ:LGVNLongeveron Inc
04/18/20244:05PMGlobeNewswire Inc.Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingNASDAQ:LGVNLongeveron Inc
04/17/20248:00AMGlobeNewswire Inc.Longeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsNASDAQ:LGVNLongeveron Inc
04/15/20248:30AMGlobeNewswire Inc.Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)NASDAQ:LGVNLongeveron Inc
04/11/20245:17PMGlobeNewswire Inc.Longeveron Announces Closing of $5.2 Million Public OfferingNASDAQ:LGVNLongeveron Inc
04/08/20242:15PMGlobeNewswire Inc.Longeveron Announces Pricing of $5.25 Million Public OfferingNASDAQ:LGVNLongeveron Inc
04/08/20248:30AMGlobeNewswire Inc.Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and GoalsNASDAQ:LGVNLongeveron Inc
11/14/20238:17AMGlobeNewswire Inc.IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc.NASDAQ:LGVNLongeveron Inc
09/07/20238:30AMGlobeNewswire Inc.IBN Coverage Initiated for Longeveron Inc.NASDAQ:LGVNLongeveron Inc
09/06/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
08/22/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
08/22/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
08/22/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGVNLongeveron Inc
08/18/20234:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGVNLongeveron Inc
 Showing the most relevant articles for your search:NASDAQ:LGVN

Your Recent History

Delayed Upgrade Clock